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Abstract  
Various Nile tilapia strains arecultured in Indonesia. This study was conducted to examine the growth response 
of four Nile tilapia strains, namely SULTANA (superior selected tilapia strain from Selabintana), NIRWANA 
(tilapia strain from Wanayasa), SRIKANDI (salinity resistant improvement from Sukamandi), and red tilapia 
fed on diet containing recombinant Epinephelus lanceolatus growth hormone (rElGH). In the first study, red 
tilapia were reared in 200-L glass aquaria and fed on artificial diet with different doses of crude rElGH protein, 
namely 0 (control), 0.03, 0.30, and 3.00 mg/kg diet. The results showed that growth, specific growth rate (SGR), 
and feed conversion ratio (FCR) were notsignificantly differentamongtreatments (p>0.05), but significantly 
different when comparedto the control (p<0.05).The second study was performed in the hapa (2x1x1m3) settled 
in a concrete pond (20x10x1.5 m3). By using 3 mg rElGH/kg diet, the results ofthesecond study showed that the 
highest (p<0.05) SGR was obtained in SULTANA (3.73%), followed by NIRWANA (3.41%). SRIKANDI 
(3.36 %),and red tilapia (3.14%) strain. Lowest FCR (p<0.05) was found in SULTANA (0.84), followed by 
NIRWANA (0.99), SRIKANDI (1.02), and red tilapia (1.22) strains. Survival of the four strains were similar, 
ranging from 84.67 to 90.00% (p>0.05). The highest (p<0.05) liver and muscle glycogen, protein and fat 
retention, and RNA/DNA ratio were found in SULTANA, followed by NIRWANA,  SRIKANDI,  and red 
tilapia.   
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As conclusion, SULTANA Nile tilapia strain showed high growth response on rElGH oral administration, and 
farming of this strain can be helpful to increase aquaculture production level. 
 
Keywords: Nile tilapia;recombinant growth hormone; RNA/DNA ratio; strains. 
 
1. Introduction 
Growth hormone (GH) plays an important role in the growth of vertebrate organisms. Natural GH levels are 
relatively low and isolation method is complicated making its application uneconomical and impractical, 
therefore the recombinant DNA technology has been appliedto produce recombinant growth hormone (rGH) [1].  
Recombinant growth hormone (rGH) from a variety of vertebrate species, including fish has been produced in 
large quantity using a bioreactor such as bacterium Escherichia coli [2,3,4],and the yeast Pichia pastoris[5]. 
Studies investigating the use of rGHbioactivity for promoting growth have been performed on fish, shrimp, and 
oyster [4,5,6,7].  Furthermore, studies investigating the use of rGH for promoting growth have been performed 
in various species, including tilapia [4,5,8,9], salmonids[1], goldfish [2], rainbow trout [10], black 
seabream[11], rabbitfish [12], Japanese flounder [13], Indonesian eel [14], giant gouramy [15,16], and white 
shrimp Litopenaeus vannamei [17]. 
The rate of growth due to rGH administration can be influenced by the type of rGH [4,18], species and age of 
the target fish (species-specific and age-dependent) [19], dose [9,15,16], and the method of administration by 
injection, immersion, oral, or a combination of immersion and oral [14]. Three types of rGH has been made in 
Indonesia, namely carp rGH (rCcGH), giant gouramy rGH (rOgGH) and giant grouper rGH (rElGH).  In 
addition, weight gain improvement of Nile tilapia juvenile after injected using rElGH (20.94%)  was higher than 
injected using rCcGH (18.09%), and rOgGH (16.99%) [4].  Moreover, orally dose of 30 mg rCcGH per kg of 
feed which was given twice times a week for sequential three weeks resulted weight gain improvement 35% 
higher than control [9]. 
Various varieties of tilapia (Oreochromis niloticus) breeding program with the main purpose of growth 
promotion has been launched in Indonesia with the decree of the Minister of Marine and Fisheries, including 
tilapia strain from  Wanayasa, NIRWANA (KEP.45/MEN 2006, 14th December, 2006), and superior selected 
tilapia strain from Selabintana, SULTANA (KEP.28/MEN/2012, 7th June, 2012). Strain SULTANA and 
NIRWANA were produced using family selection. In addition, hybridization between NIRWANA and blue 
tilapia (O. aureus) produced salinity resistant improvement from Sukamandi, SRIKANDI (KEP.09/MEN/2012, 
1stMay, 2012) with the main target was salinity tolerant. Red tilapia strain was hybridization between 
Oreochromis niloticus and Oreochromis honorum. Body color of SULTANA, NIRWANA, and SRIKANDI 
strains are gray-black, gray-green, and gray bluish green, while red tilapia body color rangging from reddish to 
reddish yellow. 
Effective dose of giant grouper growth hormone (rElGH) administration and growth response of different strains 
to the rGH administration in tilapia is still unknown. The aim of this study was to evaluate theoptimum dose  of 
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rElGH usage and the growth response of four tilapia strains (SULTANA, NIRWANA, SRIKANDI, and red 
tilapia) on rElGH oral administration. 
2. Methods 
Production of rElGH and feed preparation  
Escherichia coliBL21strain harboring the pCold-ElGH protein expression vector was used as a bioreactor for 
producing rElGH. Bacterial culture, extraction and verification of inclusion body containing rElGH were 
performed according to [4].Bacterial cells were lisated by lisozym, inclusion bodies containing  rElGH were 
washed several times by PBS (16 mM Na2HPO4·2H2O, 4 mM NaH2PO4·2H2O, 120 mMNaCl, pH 7.4), 
freezed dried and then kept at -20 °C until used. The rElGH supplemented diet was prepared according to [9]. 
The rElGH were dissolved in 15 mL PBS solution, mixed with chicken yolk egg of 2 mg/kg diet, and then 
sprayed onto 100 g commercial feed (protein content:32%). Diets were air dried and then kept at -20oC until it 
given to the fish. 
2.1. First Study 
Four level of rElGH doses were tested, namely 0 (control diet; CD), 0.03 (test diet 1; TD1), 0.3 (TD2) and 3.0 
mg/kg diet (TD3) with nutrient composation are presented inTable1. Completely randomized design using three 
treatments, two controls with three replications was applied in this study. 
Table 1. Proximate fed diet containing recombinantgiant grouper growth hormone (rElGH) and 
control  
Nutrition composition 
rElGH fed diet Control 
3.00 mg/kg 0.30 mg/kg 0.03 mg/kg Control-1 Control-2 
Protein (%) 31.62 31.52 31.17 30.81 32.35 
Fat (%) 3.97 4.18 4.22 4.13 3.40 
Crude Fiber (%) 1.20 1.02 1.03 1.35 1.70 
NFE (%) 41.07 41.75 41.55 41.72 44.63 
Ash (%) 8.32 8.38 8.76 8.57 8.78 
Water content (%) 13.82 13.15 13.27 13.42 9.14 
DE (kcal/kg diet) 2455.02 2485.53 2471.52 2455.88 2523.40 
Ratio C/P(kcal/g protein) 7.76 7.89 7.93 7.97 7.80 
Control-1: commercial diet was sprayed by chicken yolk egg  only.  Control-2  original commercial feed 
diet.NFE : Nitrogen free extract.  DE (digestible energy) is  calculatedfrom energy in protein 1 g = 3.5 kcal, fat 
8.1 kcal, and carbohydrate 1 g = 2.5 kcal. 
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Red tilapia juvenile (average body weight: 3.5±0.5 g) were obtained from Experimental Station of Aquaculture 
Department, IPB.  Fish (n= 25) were reared in the 200 L glass aquaria equipped with aeration for eight  weeks. 
Adaptation to commercial diet was performed for one week before treatments began. Fish were fed with TDat 
interval of two days three times daily (07.30-08.30, 12.00-13.00,and 16.30-17.30 o’clock) at satiation for one 
month, and CD for the rest days.Feces and uneaten diet were siphoned every day, and water was changed 100% 
of volume in every 2 days. 
The effectiveness of rElGHadministration was determined based on the average weight gain (∆W), specific 
growth rate (SGR), feed conversion ratio (FCR), and survival rate (SR). Total body weights were measured 
every 2 weeks. Survival was calculated at the end of the study. Data are presented as mean ± standard deviation 
(SD).  Statistical significance was assessed by a one-way analysis of variance followed by Fisher test using 
Minitab 16. 
2.2. Second Study 
In the second study, completely randomized design using four treatments namely (A) SULTANA, (B) 
NIRWANA (C) SRIKANDI, and (D) red tilapia with three replications was applied in this study.SULTANA 
strain was obtained from Sukabumi Main Center for Freshwater Aquaculture Development, NIRWANA strain 
from Wanayasa Center for Freshwater Fish Seed Development, SRIKANDI strain from Sukamandi Research 
Center for Fish Genetic Improvement, and red tilapia from Experimental Station of Aquaculture Department, 
IPB Bogor. The fish (avarage body weight 5.80±0.19 g) were reared in the hapa (2x1x1 m3) settled in a concrete 
pond (20x10x1.5 m3) at density of 50 fish/hapafor ten weeks. Similar at the first study, the fish were adapted for 
one week before treatment, than fed with diet containing3 mg/kg rElGH at satiation, at interval two days, three 
time daily for one month, than commercial diet was given at the rest days. The condition of water qualities 
during teen weeks  experiment were  temperature: 24 – 31 oC, pH: 6.0 - 6.5, and DO: 6-7 mg/L. 
The effectiveness of fed on diet containing rElGH determined based on∆W, SGR, FCR, SR, protein and fat 
retention, liver and muscle glycogen, and RNA/DNA ratio.  Total body weights were measured every two 
weeks,survival rate and feed conversion ratio was calculated at the end of the study. Protein retention, fat 
retention, liver glycogen and muscle glycogen were determined according to[20]obtained from three individual 
duplicate pooled samples. RNA and DNA concentration were measured using the gene quant calculator. Total 
RNA and DNA were extracted from the liver of fish after ten weeks rearing periode using isogen (Nippon Gene, 
Tokyo, Japan) and Puregene®Core Kit A kit (QIAGEN Science Marylan USA). Statistical significance was 
assessed by a one-way analysis of variance followed by Fisher Test using Minitab 16.  
3. Results and Discussion  
3.1. First Study 
 
The result of the first study showed that all rElGH treatments allowed higher in biomass, ∆W, SGR, and FCR 
compared to controls (p<0.05), while the survival rate was not significanly different (p>0.05; Table 2). 
Furthermore the biomass, ∆W, SGR, and FCR among the treatments were similar (p> 0.05). 
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Table 2. Initial biomass (IB), final biomass (FB), growth (∆W), specific growth rate (SGR), feed conversion 
ratio (FCR), and survival rate (SR) of red tilapia fed on diet containing recombinant giant grouper growth 
hormone (rElGH) 
Parameter 
          Treatment           Control 
3.00 mg/kg 0.30 mg/kg 0.03 mg/kg Control-1 Control-2 
IB (g)  104.85±1.34a 104.72±0.99a 105.72±1.01a 105.08±1.54a 105.15±0.92a 
FB (g) 703.60±21.80a 685.20±41.35a 669.91±19.15a 562.24±60.67b 559.89±60.56b 
∆W (g) 589.74±21.69a 580.48±42.01a 564.17±18.12a 457.16±60.67b 454.70±60.25b 
SGR (%)     3.46±0.06a   3.41±0.13a    3.35±0.04a    3.03±0.21b    3.02±0.20b 
FCR   1.07±0.04a 1.14±0.06a    1.14±0.03a    1.38±0.17b    1.40±0.19b 
SR (%) 93.33±2.31a 93.33±2.31a   90.67±2.31a   93.33±2.31a  93.33±2.31a 
∆W:C2 (%) 31.68  27.66  24.07  0.54 0.00 
Fish were reared in the 200-L glass aquaria for 8 weeks. Control-1: commercial diet was sprayed by chicken 
yolk egg  only.  Control-2:  original commercial feed diet.Different superscript letters in the same line indicate 
significantly difference (p<0.05). 
The results of these experiments indicate that the administration of rElGH orally at a dose of 0.03 to 3.00 mg/kg 
feed gave the same growth response and could increase growth of 24.07 to 31.68 %.  Based on the value of feed 
conversion ratio, to produce 1 kg of biomass  rElGH oral administration at dose 0.03 to 3.00 mg/kg feed   can 
save 18.57 to 23.57 %  amount of feed. When referring to [9] who reported recombinant common carp growth 
hormone (rCcGH) administration on tilapia, this experiment showed that the administration of recombinant 
giant grouper growth hormone (rElGH) more effective and efficient by reducing 10 to 100 times of the dose. 
Similar finding was reported by [4] who concluded that oral administration of recombinant giant grouper growth 
hormone (rElGH) was the best compared to oral administration of recombinant common carp growth hormone 
(rCcGH) and recombinant giant gouramy growth hormone (rOgCH).   
Among the three level doses tested in this experiment can be argued that the administration of rElGH to increase 
the growth of red tilapia at  dose of 0.03 mg/kg feed showed efficiently the best. 
3.2. Second Study 
 
SULTANA strain showed the best growth  (∆W and SGR)  than other strains (p<0.05; Table 3).  Meanwhile,  
the survival rate of all strains were not significantly different (p>0.05), so the differences in growth between the 
strains were not caused by differences in the density of culture.  
Fish were reared in the same pond and placed randomly in hapa. Thus, the differences growth response 
betweenstrains on rElGH administration allegedly associated with their superiority due to historical breeding 
program. The difference between the growth response to administration of rGH strains have also been reported 
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by [21] on different catfish strains (strains Norris and USDA-103) were given recombinant bovine growth 
hormone (rbGH). 
Table 3. Initial biomass (IB) and final biomass (FB), growth (∆W), specific growth rate (SGR), survival rate 
(SR) of four different Nile tilapia strains fed on diet containing recombinant Epinephelus lanceolatus growth 
hormone (rElGH). 
Parameter 
Strain  
SULTANA NIRWANA SRIKANDI Red tilapia 
IB (g)    276.04±5.84a      293.25±5.88a 294.29±2.21a 296.74±3.68a 
FB (g) 3584.69±32.53a 3069.86±172.50b 2987.13±180.87b 2581.06±105.48c 
∆W (g) 3308.65±32.17a 2776.61±177.57b 2692.84±182.33b 2284.32±108.10c 
SGR (%)       3.73±0.03a    3.41±0.11b     3.36±0.10b     3.14±0.08c 
SR (%)    91.33±2.31a 9.33±1.16a   88.67±1.16a   88.67±2.31a 
Fish were reared in the hapa(2x1x1 m3) settled in a concrete pond (20x10x1.5 m3) for 10 weeks. ∆W: final 
biomass – initial biomass. Different superscript letters in the same line indicate significantly difference (p<0.05). 
In line with the growth response to rElGH administration (Table 3). SULTANA strain have metabolic response 
(feed conversion ratio, levels of liver glycogen, muscle glycogen, protein retention, fat retention) and molecular 
(ratio of RNA/DNA) were highest compared to the other three strains (p <0.05).  NIRWANA and SULTANA 
feed conversion rate  were not different (p>0.05), and both of them were better  than SRIKANDI and red tilapia 
strains (p<0.05). Levels of glycogen, protein and fat retention, and the ratio of RNA/DNA in NIRWANA and 
SRIKANDI strains were not different (p>0.05), but higher than the red tilapia strain (Table 4). 
The highest retention of protein and fat in SULTANA strain indicated that protein and fat  were not much 
overhauledfor energy, and bioconversion of carbohydrates occur. [22] reported that the main biological effects 
of GH are mediated growth, especially the growth of body and bone, stimulates protein synthesis in several 
tissues, mobilize lipids from adipose tissue via gluconeogenesis, increase glycogen deposits in the liver. The 
results of study [23,24]proved that one of the biological effects of GH is to stimulate protein synthesis in several 
tissues of the body as well as reducing the need for amino acids to suppress proteolysis process.  
The growth rate can be predicted using the value of the ratio of RNA/DNA [25].  In this study SULTANA strain 
showed highest growth rate and ratio of RNA/DNA value than the other three strains. Nevertheless, total RNA 
does not directly indicate a specific gene that induced by the administration of rGH. By using a semi-
quantitative method, gene expression of insulin-like growth factor-1 (IGF-1) increased after administration of 
rGH in tilapia [9]. With these facts have alleged that the expression of IGF-1 in SULTANA strain is highest 
than other strains. Further research is needed to clarified more information about endogenous factors that 
differentiate between strains of tilapia in response to administration of rElGH. 
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Tabel 4.  Feed conversion ratio (FCR),  liver and muscle glycogen, protein and fat retention, and RNA/DNA 
ratio of four different Nile tilapia strains fed on diet containing recombinant giant grouper growth hormone 
(rElGH). 
Parameter 
Tilapia Strain  
SULTANA NIRWANA SRIKANDI Red tilapia 
  FCR    0.84±0.02c        0.99±0.07c        1.02±0.07b 1.22±0.06a 
Liver glycogen (mg/100 mL)     0.49±0.02a        0.34±0.01b 0.26±0.06bc 0.17±0.03c 
Muscle glycogen (mg/100 mL)    4.10±0.07a        3.65±0.14b  2.51±0.65bc 2.35±0.50c 
Protein Retention (%)  59.56±1.35a      53.72±0.51b       49.78±0.86b 43.94±3.02c 
Fat Retention (%) 206.52±14.48a 157.63±6.77bc 168.11±0.87b 138.33±8.86c 
RNA/DNA ratio 0.57±0.01a        0.47±0.01b 0.47±0.00b 0.24±0.00c 
Fish were reared in the hapa(2x1x1 m3) settled in a concrete pond (20x10x1.5 m3) for 10 weeks. Different 
superscript letters in the same line indicate significantly difference (p<0.05). 
Considering growth rate and feed conversion ratio values, culture of SULTANA strain has potential to increase 
production and efficiency of tilapia culture. Generally the culture periode of  tilapia in freshwater pondto reach 
marketable size (300-500 g/fish) ranging from four to six months. In this experiment administration of rElGH 
for one month, then the fish cultured for 1.5 months without administration rElGH (Figure 1). According to 
[14,26]who were studied Indonesian eel and white shrimp respectively, reported that  twice administration of 
recombinant giant grouper growth hormone (larva and nursery stages) indicated better than single administration 
(at larva or nursery stage only). Therefore, second administration of recombinant giant grouper growth hormone 
(rElGH) in tilapia SULTANA strains can allegedly trigger the growth and production becomes higher. 
 
Fig 1. Weight gain biomass of four Nile tilapia strains fed on diet containing a recombinan giant grouper growth 
hormone (rElGH) 
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4. Conclusions 
1. Oral administration of recombinant giant grouper growth hormone (rElGH) at dose 0.03 to 3.00 mg/kg 
of feed was effective in improving the growth of red tilapia by increasing 24.07 to 31.68% of weight gain. 
2. SULTANA, NIRWANA, SRIKANDI, and red tilapia strains revealed different growth response to oral 
administration of recombinant giant grouper growth hormone (rElGH). Among four tested of tilapia 
strains, SULTANA strain showed the best growth response and increased 44.84 % of weight gain 
compared to Red tilapia. 
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